Vanessa Fontana

2.4k total citations
46 papers, 975 citations indexed

About

Vanessa Fontana is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Vanessa Fontana has authored 46 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 13 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Epidemiology. Recurrent topics in Vanessa Fontana's work include Blood Pressure and Hypertension Studies (17 papers), Hormonal Regulation and Hypertension (11 papers) and Cardiovascular Health and Disease Prevention (9 papers). Vanessa Fontana is often cited by papers focused on Blood Pressure and Hypertension Studies (17 papers), Hormonal Regulation and Hypertension (11 papers) and Cardiovascular Health and Disease Prevention (9 papers). Vanessa Fontana collaborates with scholars based in Brazil, United Kingdom and United States. Vanessa Fontana's co-authors include Heitor Moreno, José E. Tanus‐Santos, A. Sabbatini, Ana Paula de Faria, Natália R. Barbaro, Rodrigo Modolo, Raquel F. Gerlach, Marcelo R. Luizon, Riccardo Lacchini and Carla S. Ceron and has published in prestigious journals such as The FASEB Journal, British Journal of Pharmacology and Molecules.

In The Last Decade

Vanessa Fontana

46 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanessa Fontana Brazil 20 449 228 164 140 133 46 975
Guangzhi Chen China 18 244 0.5× 246 1.1× 123 0.8× 140 1.0× 215 1.6× 40 988
Koichi Handa Japan 19 320 0.7× 131 0.6× 80 0.5× 381 2.7× 135 1.0× 48 1.1k
Robert N. Schuck United States 17 110 0.2× 276 1.2× 105 0.6× 162 1.2× 115 0.9× 43 855
Ling Tu China 19 121 0.3× 275 1.2× 168 1.0× 318 2.3× 139 1.0× 59 1.1k
Robert Fischer Germany 16 441 1.0× 321 1.4× 173 1.1× 385 2.8× 117 0.9× 36 1.6k
Sibel Ertek Türkiye 16 139 0.3× 264 1.2× 151 0.9× 159 1.1× 97 0.7× 38 943
Susana Vallejo Spain 20 258 0.6× 182 0.8× 244 1.5× 381 2.7× 161 1.2× 29 1.2k
Eleni Nakou Greece 10 238 0.5× 228 1.0× 127 0.8× 122 0.9× 87 0.7× 27 748
Sam Rebello United States 21 357 0.8× 143 0.6× 256 1.6× 215 1.5× 63 0.5× 58 1.1k
Rania Nasrallah Canada 17 192 0.4× 234 1.0× 165 1.0× 402 2.9× 63 0.5× 34 1.2k

Countries citing papers authored by Vanessa Fontana

Since Specialization
Citations

This map shows the geographic impact of Vanessa Fontana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Fontana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Fontana more than expected).

Fields of papers citing papers by Vanessa Fontana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Fontana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Fontana. The network helps show where Vanessa Fontana may publish in the future.

Co-authorship network of co-authors of Vanessa Fontana

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Fontana. A scholar is included among the top collaborators of Vanessa Fontana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Fontana. Vanessa Fontana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sergaki, Chrysi, et al.. (2023). The interplay between the microbiome and colonic immune system in checkpoint inhibitor therapy. PubMed. 2. 1061193–1061193. 1 indexed citations
2.
Fontana, Vanessa, Richard M. Turner, Ben Francis, et al.. (2022). Chromosomal Region 11p14.1 is Associated with Pharmacokinetics and Pharmacodynamics of Bisoprolol. Pharmacogenomics and Personalized Medicine. Volume 15. 249–260. 6 indexed citations
3.
Turner, Richard M., Vanessa Fontana, Richard J. Fitzgerald, Andrew P. Morris, & Munir Pirmohamed. (2019). Investigating the clinical factors and comedications associated with circulating levels of atorvastatin and its major metabolites in secondary prevention. British Journal of Clinical Pharmacology. 86(1). 62–74. 12 indexed citations
4.
Pisa, F. Di, Giacomo Landi, Cecilia Pozzi, et al.. (2017). Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity. Molecules. 22(3). 426–426. 39 indexed citations
5.
Barbaro, Natália R., et al.. (2015). Vascular Damage in Resistant Hypertension: TNF-Alpha Inhibition Effects on Endothelial Cells. BioMed Research International. 2015. 1–8. 28 indexed citations
6.
Ritter, Alessandra Mileni Versuti, Vanessa Fontana, Ana Paula de Faria, et al.. (2015). Association of Mineralocorticoid Receptor Polymorphism I180V With Left Ventricular Hypertrophy in Resistant Hypertension. American Journal of Hypertension. 29(2). 245–250. 11 indexed citations
7.
8.
Faria, Ana Paula de, María Ondina Paganelli, A. Sabbatini, et al.. (2014). Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients. American Journal of Hypertension. 28(2). 200–207. 6 indexed citations
9.
Fontana, Vanessa, Marcelo R. Luizon, & Valéria C. Sandrim. (2014). An update on the pharmacogenetics of treating hypertension. Journal of Human Hypertension. 29(5). 283–291. 29 indexed citations
10.
Faria, Ana Paula de, Rodrigo Modolo, Vanessa Fontana, & Heitor Moreno. (2014). Adipokines: Novel Players in Resistant Hypertension. Journal of Clinical Hypertension. 16(10). 754–759. 24 indexed citations
11.
Fontana, Vanessa, Ana Paula de Faria, Natália R. Barbaro, et al.. (2013). Modulation of aldosterone levels by −344 C/T CYP11B2 polymorphism and spironolactone use in resistant hypertension. Journal of the American Society of Hypertension. 8(3). 146–151. 14 indexed citations
12.
Sabbatini, A., Ana Paula de Faria, Natália R. Barbaro, et al.. (2013). Deregulation of adipokines related to target organ damage on resistant hypertension. Journal of Human Hypertension. 28(6). 388–392. 37 indexed citations
13.
Demacq, Caroline, Valéria Nasser Figueiredo, A. Sabbatini, et al.. (2013). Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension. Hypertension Research. 36(12). 1067–1072. 37 indexed citations
14.
Faria, Ana Paula de, Natália R. Barbaro, Rodrigo Modolo, et al.. (2013). Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension. European Journal of Clinical Pharmacology. 70(2). 147–154. 14 indexed citations
15.
Fontana, Vanessa, et al.. (2012). eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril. European Journal of Clinical Pharmacology. 69(2). 167–177. 41 indexed citations
16.
Oliveira, Renê Donizeti Ribeiro de, Vanessa Fontana, Cristina M. Junta, et al.. (2012). Differential Gene Expression Profiles May Differentiate Responder and Nonresponder Patients with Rheumatoid Arthritis for Methotrexate (MTX) Monotherapy and MTX plus Tumor Necrosis Factor Inhibitor Combined Therapy. The Journal of Rheumatology. 39(8). 1524–1532. 15 indexed citations
17.
Fontana, Vanessa, et al.. (2012). Comprehensive Evaluation of the Effects of Enalapril on Matrix Metalloproteinases Levels in Hypertension. Cardiovascular Drugs and Therapy. 26(6). 511–519. 19 indexed citations
18.
Fontana, Vanessa, et al.. (2011). Consistent Alterations of Circulating Matrix Metalloproteinases Levels in Untreated Hypertensives and in Spontaneously Hypertensive Rats: A Relevant Pharmacological Target. Basic & Clinical Pharmacology & Toxicology. 109(2). 130–137. 44 indexed citations
19.
Fontana, Vanessa, et al.. (2011). Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. European Journal of Clinical Pharmacology. 67(4). 365–370. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guangzhi Chen Breakdown of academic impact, for papers by Koichi Handa Breakdown of academic impact, for papers by Robert N. Schuck Breakdown of academic impact, for papers by Ling Tu Breakdown of academic impact, for papers by Robert Fischer Breakdown of academic impact, for papers by Sibel Ertek Breakdown of academic impact, for papers by Susana Vallejo Breakdown of academic impact, for papers by Eleni Nakou Breakdown of academic impact, for papers by Sam Rebello Breakdown of academic impact, for papers by Rania Nasrallah
Rankless by CCL
2026